BIODEL INC's ticker is BIOD and the CUSIP is 09064M204. A total of 40 filers reported holding BIODEL INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $602,000 | +26.7% | 1,394,085 | -8.8% | 0.00% | – |
| Q2 2016 | $475,000 | -1.0% | 1,528,974 | +5.1% | 0.00% | – |
| Q1 2016 | $480,000 | +25.7% | 1,455,033 | +30.5% | 0.00% | – |
| Q4 2015 | $382,000 | -99.8% | 1,114,814 | -83.3% | 0.00% | -100.0% |
| Q3 2015 | $174,473,000 | +24132.4% | 6,672,832 | +855.8% | 0.01% | – |
| Q2 2015 | $720,000 | +7.1% | 698,121 | +23.7% | 0.00% | – |
| Q1 2015 | $672,000 | -3.0% | 564,456 | +8.3% | 0.00% | – |
| Q4 2014 | $693,000 | -19.0% | 521,319 | +1.7% | 0.00% | – |
| Q3 2014 | $856,000 | -19.8% | 512,499 | +3.7% | 0.00% | – |
| Q2 2014 | $1,067,000 | -19.5% | 494,244 | +1.9% | 0.00% | – |
| Q1 2014 | $1,325,000 | +36.6% | 485,144 | +15.0% | 0.00% | – |
| Q4 2013 | $970,000 | -21.8% | 421,769 | +7.1% | 0.00% | – |
| Q3 2013 | $1,241,000 | -22.5% | 393,869 | +2.8% | 0.00% | – |
| Q2 2013 | $1,602,000 | – | 383,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST NEW YORK SECURITIES LLC /NY | 271,234 | $452,961,000 | 0.32% |
| Broadfin Capital, LLC | 1,330,034 | $2,221,000 | 0.23% |
| FNY Managed Accounts LLC | 32,000 | $53,440,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 1,492,803 | $2,493,000 | 0.10% |
| Rotella Capital Management, Inc. | 29,224 | $49,000 | 0.05% |
| SHEPHERD KAPLAN KROCHUK, LLC | 65,225 | $109,000 | 0.01% |
| Orbimed Advisors | 209,700 | $350,000 | 0.00% |
| First Allied Advisory Services, Inc. | 20,000 | $33,000 | 0.00% |
| TFS CAPITAL LLC | 14,017 | $23,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 1,470 | $2,000 | 0.00% |